We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
FDA批准Auvelity用于治疗阿尔茨海默病患者的激越症状。首个无死亡风险的非抗精神病药物。了解新的治疗标准。
